New drugs in oncology: Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel ; München u.a.
Karger
1989
|
| Schriftenreihe: | Beiträge zur Onkologie
37 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | VIII, 302 S. graph. Darst. |
| ISBN: | 3805550472 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV001881926 | ||
| 003 | DE-604 | ||
| 005 | 20070308 | ||
| 007 | t | ||
| 008 | 890821s1989 d||| |||| 10||| eng d | ||
| 020 | |a 3805550472 |9 3-8055-5047-2 | ||
| 035 | |a (OCoLC)645353833 | ||
| 035 | |a (DE-599)BVBBV001881926 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 |a DE-355 |a DE-29 |a DE-188 |a DE-578 | ||
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 084 | |a XH 1500 |0 (DE-625)152870:12905 |2 rvk | ||
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a New drugs in oncology |b Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 |c Vol. ed. W. Queißer ... |
| 264 | 1 | |a Basel ; München u.a. |b Karger |c 1989 | |
| 300 | |a VIII, 302 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Beiträge zur Onkologie |v 37 | |
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1988 |z Frankfurt am Main |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 2 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Queißer, Wolfgang |d 1936- |e Sonstige |0 (DE-588)115699325 |4 oth | |
| 710 | 2 | |a Deutsche Krebsgesellschaft |b Arbeitsgemeinschaft für Internistische Onkologie |b Phase-Zwei-Studiengruppe |e Sonstige |0 (DE-588)2106851-3 |4 oth | |
| 711 | 2 | |a Symposium Neue Substanzen in der Onkologie |d 1988 |c Frankfurt am Main |j Sonstige |0 (DE-588)2106838-0 |4 oth | |
| 830 | 0 | |a Beiträge zur Onkologie |v 37 |w (DE-604)BV000000016 |9 37 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001241065&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001241065 | ||
Datensatz im Suchindex
| _version_ | 1804116341489139712 |
|---|---|
| adam_text | SYMPOSIUM OF THE PHASE II STUDY GROUP OF THE ASSOCIATION FOR MEDICAL
ONCOLOGY OF THE GERMAN CANCER SOCIETY, NEUE SUBSTANZEN IN DER
ONKOLOGIE , FRANKFURT/MAIN, NOVEMBER 17TH AND 18TH, 1988 NEW DRUGS IN
ONCOLOGY VOLUME EDITORS W. QUEISSER, MANNHEIM; H. H. FIEBIG, FREIBURG 38
FIGURES AND 122 TABLES, 1989 BASEL * MUENCHEN * PARIS * LONDON * NEW YORK
* NEW DELHI * BANGKOK * SINGAPORE * TOKYO * SYDNEY CONTENTS PREFACE IX
PHASE I STUDIES SCHOEBER, C; KOEHNE-WOEMPNER, H.; STAHL, M.; HARSTRICH, A.;
HANAUSKE, A.; POLIWODA, H.; WILKE, H.; SCHMOLL, H.-J.: A PILOT STUDY OF
5-FLUOROURACIL WITH HIGH-DOSE FOLINIC ACID PLUS DIPYRIDAMOLE IN
COLORECTAL CANCER 1 FROMM, M.; BERDEL, W. E.; SCHICK, H. D.;
DANHAUSER-RIEDL, S.; FINK, U.; REMY, W.; PRAEUER, H. W.; SIEWERT, J. R.;
ANKELE, A.; REICHERT, A.; RASTETTER, J.: EXPERIENCE WITH THE
POLYELECTROLYTE CARBETIMER IN EARLY CLINICAL TRIALS 12 RICHEL, D. J.;
COLLY, L. P.; LURVINK, E.; WILLEMZE, R.: ACTIVITY OF 5 AZA-2-DEOXY-
CYTIDINE IN ARA-C RESISTANT AND SENSITIVE LEUKEMIA 20 HORMONE-ACTIVE
SUBSTANCES HOLTKAMP, W.; AMMON, A.; MARSCHNER, N.; NAGEL, G. A.:
CABERGOLINE SUPPRESSION OF PROLACTIN LEVELS IN METASTATIC BREAST CANCER
PATIENTS 30 STAMM, H. E.; KIENINGER, G.; KURZ, L.; STURM, R.; STAAB,
H.-J.; PECHAN, R.; HEIL, M.; HUBER, H.-J.: PHASE I STUDIES WITH THE NEW
ANTIESTROGEN DROLOXIFENE: TOLERABIL- ITY AFTER SINGLE AND MULTIPLE DOSES
AND ON DOSE ESCALATION 36 SINDERMANN, H.; COOMBES, R. C; PARIDAENS, R.;
PEUKERT, M.; VON ANGERER, E.: ZIN- DOXIFENE: CLINICAL PHASE I STUDIES IN
PATIENTS WITH ADVANCED BREAST CANCER ... 45 KAUFMANN, M.; POSSINGER, K.;
ILLIGER, H. J.; SCHMID, H.; HIETANEN, T.; JOHANSSON, R.; PYRHOENEN, S.;
VALAVAARA, R.; SINDERMANN, H.: TOREMIFENE: CLINICAL PHASE II/III TRIALS
OF A NEW ANTIESTROGEN IN PATIENTS WITH ADVANCED BREAST CANCER 50
POSSINGER, K.; WAGNER, H.; JONAT, W.; HOEFFKEN, K.; BECHER, R.; KUNZ,
TH.: PHASE II STUDY OF A NEW AROMATASE INHIBITOR,
4-HYDROXY-ANDROSTENEDIONE, FOR THE TREATMENT OF WOMEN WITH ADVANCED
BREAST CARCINOMA 58 CONTENTS VI ANTHRACYCLINES MROSS, K.; LANGENBUCH,
T.; BURK, K.; MAYER, U.; KAPLAN, E.; HOSSFELD, D. K.: PHASE I STUDY WITH
IODO-DOXORUBICIN 64 SCHROEDER, M.; DONHUIJSEN-ANT, R.; PUREA, H.;
WESTERHAUSEN, M.: CLINICAL EXPERIENCE WITH PIRARUBICIN IN THE TREATMENT
OF PATIENTS WITH PRETREATED HEAD AND NECK CANCER 74 WORST, P.; FIEBIG,
H. H.; HARSTRICK, A.; DONHUIJSEN-ANT, R.; EDLER, L.; QUEISSER, W.:
PIRARUBICIN IN ADVANCED SOFT TISSUE SARCOMAS. A TRIAL OF THE PHASE II
STUDY GROUP OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF THE GERMAN CANCER
SOCIETY . 78 SCHEITHAUER, W.; SAMONIGG, H.; DEPISCH, D.; SCHUELLER, J.;
HAUSMANNINGER, H.; WIEGELE, J.; ZIELINSKI, CH.; STOEGER, H.; HAIDER, K.;
PREIS, P.; KASPAREK, A.; GREIFENBERG, B.; LUDWIG, H.: PIRARUBICIN
(4 -0-TETRAHYDROPYRANIL-DOXORUBICIN) FOR TREATMENT OF METASTATIC BREAST
CANCER 89 KLEEBERG, U. R.; REICHEL, L.; RAU, J.; WANDER, H. E.; ESSERS,
U.; FIEBIG, H. H.; SALEWSKI, E.; GREIFENBERG, B.; EDLER, L.: PHASE II
STUDY WITH PIRARUBICIN IN METASTATIC BREAST CARCINOMA. A TRIAL OF THE
PHASE II STUDY GROUP OF THE ASSOCIA- TION FOR MEDICAL ONCOLOGY OF THE
GERMAN CANCER SOCIETY 94 DRINGS, P; TESSEN, H. W.; GATZEMEIER, U.;
BERDEL, W. E.; STAHL, M.; EDLER, L.; SALEWSKI, E.: PHASE II STUDY OF
PIRARUBICIN (THP-DOXORUBICIN) IN ADVANCED NON-SMALL CELL LUNG CANCER.
FOR THE PHASE II STUDY GROUP OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF
THE GERMAN CANCER SOCIETY 103 HENSS, H.; ARNOLD, H.; FIEBIG, H. H.:
LOEHR, G.W.: PHASE II STUDY OF PIRARUBICIN IN SMALL CELL LUNG CARCINOMA
114 BREMER, K.; RIECHE, K.; ESSERS, U.; QUEISSER, U.: PIRARUBICIN IN
ADVANCED LOW-GRADE MALIGNANT NON-HODGKIN S LYMPHOMAS. A TRIAL OF THE
PHASE II STUDY GROUP OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF THE
GERMAN CANCER SOCIETY 119 FIEBIG, H. H.; HENSS, H.; WANDER, H. E.;
REICHEL, L.; ESSERS, U.; DONHUIJSEN-ANT, R.; FROMM, M.: PHASE II STUDY
OF ORAL IDARUBICIN IN PATIENTS WITH ADVANCED STOMACH CANCERS. A TRIAL OF
THE PHASE II STUDY GROUP OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF THE
GERMAN CANCER SOCIETY 125 WAGNER, H.; POSSINGER, K.; WORST, P.; QUEISSER,
W.; BREMER, K.; RIECHE, K.; KLEE, M.; WESTERHAUSEN, M.; DONHUIJSEN-ANT,
R.; FRITZE, D.; EDLER, L.: IDARUBICIN: FIRST- LINE CHEMOTHERAPY IN
PATIENTS WITH METASTASIZED BREAST CANCER AND FAEVORABLE PROGNOSIS 131
HENSS, H.; FIEBIG, H. H.; HOLDENER, E. E.; KAPLAN, E.: PHASE II STUDY OF
HIGH-DOSE EPIRUBICIN IN NON-SMALL CELL LUNG CANCER 136 MROSS, K.;
LANGENBUCH, T.; BURK, K.; JONAT, W.; HOSSFELD, D. K.: INTENSIVE-DOSE
EPIRUBICIN WITH AND WITHOUT HIGH-DOSE VERAPAMIL: TOXICITY,
PHARMACOKINETICS, METABOLISM AND RESPONSE IN PRETREATED PATIENTS WITH
METASTATIC BREAST CANCER. A PHASE II PILOT STUDY 141 NITROSOUREAS
GATZEMEIER, U.; DRINGS, P.; EDLER, L.; FIEBIG, H. H.; HINKE, A.; RIECHE,
K.; TESSEN, H. W.: PHASE II TRIAL USING TAUROMUSTINE IN PATIENTS WITH
EXTENDED NON-SMALL CELL LUNG CANCER. A TRIAL OF THE PHASE II STUDY GROUP
OF THE ASSOCIATION FOR MEDICAL ONCOLOGY OF THE GERMAN CANCER SOCIETY 152
CONTENTS VII FIEBIG, H. H.; HENSS, H.; ARNOLD, H.; LOEHR, G. W.: PHASE II
STUDY OF 1- (2-CHLOROETHYL)-3-(2-HYDROXYETHYL)-L-NITROSOUREA (HECNU) IN
PATIENTS WITH ADVANCED STOMACH AND LARGE BOWEL CANCERS 157 HENSS, H.;
FIEBIG, H. H.; HINKELBEIN, W.: PHASE II TRIAL OF L-(2-CHLOROETHYL)-3-
(2-HYDROXYETHYL)-L-NITROSOUREA (HECNU) IN MALIGNANT BRAIN TUMORS 163
METAL COMPLEXES HEIM, M. E.; FLECHTNER, H.; KEPPLER, B. K.; QUEISSER, W.:
CLINICAL STUDIES WITH BUCOTITANE, A NEW NON-PLATINUM METAL COMPLEX FOR
CANCER THERAPY 168 KLEEBERG, U.R.; VERSCHRAEGEN, C. F.; TRUCHETET, F.;
ISRAELS, P.; AAPRO, M.; MULDER, J.; THOMAS, D.; ROZENCWEIG, M.: PHASE II
TRIAL WITH CARBOPLATIN VERSUS IPROPLATIN IN DISSEMINATED MALIGNANT
MELANOMA. A TRIAL OF THE EORTC MELANOMA COOPERA- TIVE GROUP 176 QUEISSER,
W.; PREUSSER, P.; MROSS, K. B.; FRITZE, D.; RIECHE, K.; BEYER, J.-H.;
ACHTER- RATH, W.; EDLER, L.: PHASE II STUDY WITH CARBOPLATIN IN PATIENTS
WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS WITHOUT PRIOR
CHEMOTHERAPY. A TRIAL OF THE PHASE II STUDY GROUP OF THE ASSOCIATION FOR
MEDICAL ONCOLOGY OF THE GERMAN CANCER SOCIETY 184 GATZEMEIER, U.;
HECKMAYR, M.; HOSSFELD, D. K.; ZSCHABER, R.; ACHTERRATH, W.: CAR-
BOPLATIN IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER. A PHASE II
TRIAL . . . 191 OTHER CYTOSTATICS JACKSON, R. C; MEYER, M. B.:
TRIMETREXATE: AN UPDATE OF RECENT BASIC AND CLINICAL RESULTS 201
SCHMAEHL, A.; MANEGOLD, C.; BECKER, H.; PEUKERT, M.; DRINGS, P.: A PHASE
I/II STUDY OF ORAL IFOSFAMIDE TO DETERMINE ITS TOLERANCE AND
EFFECTIVENESS IN ADVANCED NON- SMALL CELL LUNG CANCER 207 RIECHE, K.;
DONHUIJSEN-ANT, R.; BREMER, K.; LINK, H.; BERDEL, W. E.; SINDERMANN, H.:
TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODG-
KIN S LYMPHOMA OF LOW-GRADE MALIGNANCY WITH 1,2,4-TRIGLYCIDYLURAZOL
(TGU). A PHASE II STUDY ;. . 213 ETHER LIPIDS UNGER, C.; EIBL, H.;
NAGEL, G. A.; VON HEYDEN, H. W.; BREISER, J.; ENGEL, J.; STEKAR, J.;
PEUKERT, M.; HILGARD, P.; BERGER, M.: HEXADECYLPHOSPHOCHOLINE IN THE
TOPICAL TREATMENT OF SKINMETASTASES. A PHASE I TRIAL 219 KHANAVKAR, B.;
ULBRICH, F.: GATZEMEIER, U.; MEYER-SCHWICKERATH, E.; LORENZ, J.;
SCHREML, W.; BRUGGER, R.; SCHICK, H. D.; VON PAWEL, J.; NORDSTROEM, R.;
DRINGS, P.: TREATMENT OF NON-SMALL CELL LUNG CANCER WITH THE
ALKYLLYSOPHOS- PHOLIPID EDELFOSINE. INTERMEDIATE DATA ANALYSIS 224
HERRMANN, D. B. J.; NEUMANN, H. A.; HEIM, M. E.; BERDEL, W. E.; FROMM,
M.; ANDREESEN, R.; QUEISSER, W.; BOERNER, D.; STERZ, R.; BESENFELDER, E.;
BICKER, U.: SHORT- AND LONG-TERM TOLERABILITY STUDY OF THE THIOETHER
PHOSPHOLIPID DERIVA- TIVE ILMOFOSINE IN CANCER PATIENTS 236 CONTENTS
VIII IMMUNE MODULATORS MANKE, H.-G.; AULENBACHER, P.; OSSWALD, U.;
PEUKERT, M.; DRINGS, P^: IMMUNOMODU- LATION OF LOW-DOSE MAFOSFAMIDE IN
PATIENTS WITH NON-SMALL CELL LUNG CAR- CINOMA. A PHASE I TRIAL 248
KLEIN, H. O.; COERPER, C; VOIGT, P.; GOLBACH, G.: IN VIVO MODULATION OF
THE IMMUNE SYSTEM BY MAFOSFAMIDE IN PATIENTS WITH ADVANCED RENAL CELL
CARCINOMA. A PHASE I TRIAL 255 SCHOEBER, CH.; SCHMIDT, S.; STAHL, M.;
POLIWODA, H.; HARSTRICK, A.; JONAS, U.; WILKE, H.; SCHMOLL, H.-J.: PHASE
II STUDY OF MAFOSFAMIDE IN PROGRESSIVE ADVANCED RENAL CELL CARCINOMA 259
SINDERMANN, H.; PEUKERT, M.; HILGARD, P.: MAFOSFAMIDE: MARROW PURGING IN
AUTOLO- GOUS BONE MARROW TRANSPLANTATION 265 AULENBACHER, P.; DRINGS,
P.; KEMPF, P.; MANKE, H. G.; PEUKERT, M.; SCHLAG, P.; SINDER- MANN, H.:
IMMUNOTHERAPY WITH NOCARDIA RUBRA CELL WALL SKELETON (RUBRATIN) 271
DRINGS, P.; MANKE, H. G.; GUENTHER, I.; AULENBACHER, P.; PEUKERT, M.:
IMMUNOMODULATING ACTIVITY OF RUBRATIN. RESULTS OF A PHASE II TRIAL IN
ADVANCED LUNG CANCER 279 BIOLOGICAL RESPONSE MODIFIERS HIDDEMANN, W.;
KOCH, P; ESSINK, M.; WENDT, F. C; TIERIER, R.; VAN DE LOO, J.: TREATMENT
OF LOW-GRADE NON-HODGKIN S LYMPHOMA WITH PREDNIMUSTINE/MITO- XANTRONE
FOLLOWED BY INTERFERON ALPHA-2A. A CLINICAL PHASE II STUDY 287 SCHUSTER,
D.; SCHNEIDER, G.; ADE, N.; HEIM, M. E.: RESULTS OF A MULTICENTER TRIAL
IN THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA WITH A COMBINATION OF
RECOMBI- NANT INTERFERON ALPHA-2A AND VINBLASTINE 292 SUBJECT INDEX 300
|
| any_adam_object | 1 |
| author_GND | (DE-588)115699325 |
| building | Verbundindex |
| bvnumber | BV001881926 |
| classification_rvk | VS 9100 XH 1500 XI 7000 |
| ctrlnum | (OCoLC)645353833 (DE-599)BVBBV001881926 |
| discipline | Chemie / Pharmazie Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02458nam a2200517 cb4500</leader><controlfield tag="001">BV001881926</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070308 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890821s1989 d||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805550472</subfield><subfield code="9">3-8055-5047-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)645353833</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001881926</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1500</subfield><subfield code="0">(DE-625)152870:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drugs in oncology</subfield><subfield code="b">Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988</subfield><subfield code="c">Vol. ed. W. Queißer ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; München u.a.</subfield><subfield code="b">Karger</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 302 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">37</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1988</subfield><subfield code="z">Frankfurt am Main</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Queißer, Wolfgang</subfield><subfield code="d">1936-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)115699325</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Deutsche Krebsgesellschaft</subfield><subfield code="b">Arbeitsgemeinschaft für Internistische Onkologie</subfield><subfield code="b">Phase-Zwei-Studiengruppe</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2106851-3</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Symposium Neue Substanzen in der Onkologie</subfield><subfield code="d">1988</subfield><subfield code="c">Frankfurt am Main</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2106838-0</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">37</subfield><subfield code="w">(DE-604)BV000000016</subfield><subfield code="9">37</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001241065&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001241065</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1988 Frankfurt am Main gnd-content |
| genre_facet | Konferenzschrift 1988 Frankfurt am Main |
| id | DE-604.BV001881926 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:36:58Z |
| institution | BVB |
| institution_GND | (DE-588)2106851-3 (DE-588)2106838-0 |
| isbn | 3805550472 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001241065 |
| oclc_num | 645353833 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 DE-188 DE-578 |
| owner_facet | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 DE-188 DE-578 |
| physical | VIII, 302 S. graph. Darst. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Karger |
| record_format | marc |
| series | Beiträge zur Onkologie |
| series2 | Beiträge zur Onkologie |
| spelling | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 Vol. ed. W. Queißer ... Basel ; München u.a. Karger 1989 VIII, 302 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Beiträge zur Onkologie 37 Literaturangaben Chemotherapie (DE-588)4127083-6 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1988 Frankfurt am Main gnd-content Cytostatikum (DE-588)4068347-3 s DE-604 Krebs Medizin (DE-588)4073781-0 s Pharmakotherapie (DE-588)4076066-2 s Chemotherapie (DE-588)4127083-6 s Queißer, Wolfgang 1936- Sonstige (DE-588)115699325 oth Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Phase-Zwei-Studiengruppe Sonstige (DE-588)2106851-3 oth Symposium Neue Substanzen in der Onkologie 1988 Frankfurt am Main Sonstige (DE-588)2106838-0 oth Beiträge zur Onkologie 37 (DE-604)BV000000016 37 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001241065&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 Beiträge zur Onkologie Chemotherapie (DE-588)4127083-6 gnd Pharmakotherapie (DE-588)4076066-2 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4127083-6 (DE-588)4076066-2 (DE-588)4068347-3 (DE-588)4073781-0 (DE-588)1071861417 |
| title | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 |
| title_auth | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 |
| title_exact_search | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 |
| title_full | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 Vol. ed. W. Queißer ... |
| title_fullStr | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 Vol. ed. W. Queißer ... |
| title_full_unstemmed | New drugs in oncology Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 Vol. ed. W. Queißer ... |
| title_short | New drugs in oncology |
| title_sort | new drugs in oncology symposium of the phase ii study group of the association for medical oncology of the german cancer society neue substanzen in der onkologie frankfurt main nov 17th and 18th 1988 |
| title_sub | Symposium of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society, "Neue Substanzen in der Onkologie", Frankfurt/Main, Nov. 17th and 18th, 1988 |
| topic | Chemotherapie (DE-588)4127083-6 gnd Pharmakotherapie (DE-588)4076066-2 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Chemotherapie Pharmakotherapie Cytostatikum Krebs Medizin Konferenzschrift 1988 Frankfurt am Main |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001241065&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000000016 |
| work_keys_str_mv | AT queißerwolfgang newdrugsinoncologysymposiumofthephaseiistudygroupoftheassociationformedicaloncologyofthegermancancersocietyneuesubstanzeninderonkologiefrankfurtmainnov17thand18th1988 AT deutschekrebsgesellschaftarbeitsgemeinschaftfurinternistischeonkologiephasezweistudiengruppe newdrugsinoncologysymposiumofthephaseiistudygroupoftheassociationformedicaloncologyofthegermancancersocietyneuesubstanzeninderonkologiefrankfurtmainnov17thand18th1988 AT symposiumneuesubstanzeninderonkologiefrankfurtammain newdrugsinoncologysymposiumofthephaseiistudygroupoftheassociationformedicaloncologyofthegermancancersocietyneuesubstanzeninderonkologiefrankfurtmainnov17thand18th1988 |